XML 19 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities    
Net income $ 5,615 $ 3,614
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 390 310
Accretion of discount on purchased loans (87) 0
Amortization of CDI 109 0
Earned ESOP shares 232 215
Stock option compensation expense 53 44
Net recoveries on investment securities (11) (22)
Change in fair value of investments in equity securities (8) 0
Gain on sales of OREO and other repossessed assets, net 0 (12)
Provision for OREO losses 3 94
Gain on sales of loans, net (386) (521)
Loans originated for sale (16,932) (15,193)
Proceeds from sales of loans 16,115 15,906
Amortization of MSRs 153 120
BOLI net earnings (157) (136)
Increase in deferred loan origination fees 238 38
Net change in accrued interest receivable and other assets, and other liabilities and accrued expenses 1,447 1,301
Net cash provided by operating activities 6,774 5,758
Cash flows from investing activities    
Net decrease (increase) in CDs held for investment 433 (10,494)
Proceeds from sale of investment securities available for sale 2,332 0
Proceeds from maturities and prepayments of investment securities held to maturity 580 11
Proceeds from maturities and prepayments of investment securities available for sale 644 126
Increase in loans receivable, net (10,377) (15,105)
Additions to premises and equipment (984) (199)
Cash acquired, net of cash consideration paid in business combination 14,284 0
Proceeds from sales of OREO and other repossessed assets 0 495
Net cash provided by (used in) investing activities 13,812 (25,166)
Cash flows from financing activities    
Net (decrease) increase in deposits (5,867) 38,176
Proceeds from exercise of stock options 71 61
Payment of dividends (1,911) (810)
Net cash (used in) provided by financing activities (7,707) 37,427
Net increase in cash and cash equivalents 12,879 18,019
Cash and cash equivalents, at beginning of period 148,864 [1] 148,188
Cash and cash equivalents, at end of period 161,743 166,207
Supplemental disclosure of cash flow information    
Income taxes paid 0 0
Interest paid 901 584
Supplemental disclosure of non-cash investing activities    
Loans transferred to OREO and other repossessed assets 91 163
Other comprehensive loss related to investment securities (79) (12)
Business Combination (see Note 2)    
Fair value of assets acquired 180,825 0
Fair value of liabilities assumed $ 154,625 $ 0
[1] Derived from audited consolidated financial statements.